0001209191-17-052804.txt : 20170914 0001209191-17-052804.hdr.sgml : 20170914 20170914160919 ACCESSION NUMBER: 0001209191-17-052804 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170912 FILED AS OF DATE: 20170914 DATE AS OF CHANGE: 20170914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vachon Mark CENTRAL INDEX KEY: 0001614018 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 171085773 MAIL ADDRESS: STREET 1: GOODWIN PROCTER LLP STREET 2: 53 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-09-12 0 0001293971 bluebird bio, Inc. BLUE 0001614018 Vachon Mark C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2017-09-12 4 M 0 6000 30.47 A 8000 D Common Stock 2017-09-12 4 S 0 1270 126.1469 D 6730 D Common Stock 2017-09-12 4 S 0 4730 127.0013 D 2000 D Stock Option 30.47 2017-09-12 4 M 0 6000 0.00 D 2024-07-16 Common Stock 6000 14000 D the sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2017. The range in prices for the transaction reported on this line was $125.65 to $126.60. The average weighted price was $126.1469. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The range in prices for the transaction reported on this line was $126.65 to $127.35. The average weighted price was $127.0013. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. This option vests ratably over three years in annual installments, commencing on July 16, 2014. /s/ Jason F. Cole, Attorney-in-Fact 2017-09-14